Jump to content

Haloprogin

From Wikipedia, the free encyclopedia
(Redirected from Halotex)
Haloprogin
Clinical data
Routes of
administration
Topical
ATC code
Legal status
Legal status
  • US: Not available
Identifiers
  • 1,2,4-Trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.011.169 Edit this at Wikidata
Chemical and physical data
FormulaC9H4Cl3IO
Molar mass361.38 g·mol−1
3D model (JSmol)
Melting point113.5 °C (236.3 °F)
Solubility in waterInsoluble mg/mL (20 °C)
  • Clc1cc(OCC#CI)c(Cl)cc1Cl
  • InChI=1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2 checkY
  • Key:CTETYYAZBPJBHE-UHFFFAOYSA-N checkY
  (verify)

Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections.[1] It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.

Action

[edit]

Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over-the-counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[2]

Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[3]

References

[edit]
  1. ^ Rudolph RI (December 1979). "Haloprogin as treatment for fungal infections". Clinical and Experimental Dermatology. 4 (4): 548. doi:10.1111/j.1365-2230.1979.tb01656.x. PMID 161212. S2CID 71471801.
  2. ^ "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17.
  3. ^ "Haloprogin". DrugBank. University of Alberta. Nov 6, 2006. Retrieved 2007-02-17.